Reorganizing the Global Pharmacovigilance Function

How can pharma marketers remain effective and relevant for key customers, patients, and healthcare providers (HCPs) in the time of COVID-19?

On-demand talent is a critical resource for life science and pharma companies as they innovate to keep pace with market changes, respond to emerging health threats, and adapt to a remote environment.

In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceutical company was looking to gain a deeper understanding of the current competitive...

It’s not easy to bring a new drug to market. As corporate market access functions evolve to help life science companies streamline the complex process of getting therapies into patients’ hands,...

Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.

An F200 pharma company needed an experienced principal risk management engineer to assess current processes and develop improvements to mitigate risk during development and manufacturing of...

As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other...

An F500 biotech company wanted to engage a consultant to work with its medical evidence, research, and innovation team to create and coordinate several projects related to the generation of...

The U.S. patient access team at an F200 biopharma leader was seeking a strong project manager who would support their market access and marketing teams with patient / HCPs promotions. The client...

An F200 pharma company wanted to implement next generation digital health technologies, which required a thorough review of the existing strategy across three therapeutic areas and a roadmap for...

Pursuing growth into personalized medicine and safer, more effective drug therapy, an F200 biopharmaceutical company wanted to improve its cross-functional end-to-end control strategy and tactics...

Remote work has suddenly become the new normal for independent consultants. Here are the types of work best suited for remote consulting jobs.

In the midst of a company-wide reorganization, the Cell Therapy Market Access team at an F200 pharmaceutical company needed a value and access expert to support several projects. Looking for...

John O'Hara, VP of Strategic Initiatives at Janssen, joins us to discuss J&J's framework for ethical decision-making in pharma manufacturing and supply chain related to the COVID-19 pandemic

The Global Technology Services Group of an F100 pharmaceutical company wanted to streamline global IT application development and turned to Business Talent Group when they needed support managing...

COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.

Sandy Torrekens—Lead Strategist for the UK Dept. of Health during the “Swine Flu” pandemic—joins us to discuss how life science and pharma companies can respond to COVID-19 supply chain disruption.

Speed is key in life science product development. Delays cost, as do mistakes. With independent clinical operations consultants, neither has to be an issue.